This federal contract award, with an ID of SPE2DB24D1104|SPE2DB25FXWA3, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4 mg Glimepiride tablets, a medication used to treat type 2 diabetes, with a total ceiling value of $6,674.81 and a completion date of December 30, 2024.
The award is not associated with a set-aside program and is a firm-fixed-price delivery order contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/28/25, 9:44 AM